Tag: orphan drug
Regeneron’s Ebola treatment granted FDA approval
Inmazeb is a mixture of three monoclonal antibodies and was designed to treat Zaire ebolavirus. It is the first FDA-approved treatment for Ebola virus infection in adult and pediatric patients.
Taro Pharmaceutical of Hawthorne sells U.S. rights to drug treating rare...
The pharmaceutical company in Hawthorne last spring ceased commercial sales and marketing of the "orphan" drug that was the focus of the deal.
Ardsley biotech company awarded Army contract
Acorda Therapeutics will use an Army contract award for clinical trials of a drug that could treat spinal cord injuries in combat veterans.